ARWR: Arrowhead Pharmaceuticals Inc

15.70 USD 0.56 (3.44%)

Sektor: Gesundheitswesen Basis: US Dollar Gewinnwährung: US Dollar

Der Wechselkurs von ARWR hat sich für heute um -3.44% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 15.51 bis zu einem Hoch von 16.54 gehandelt.

Verfolgen Sie die Arrowhead Pharmaceuticals Inc-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.

Vollbild-Chart

ARWR News

Investing 13:40 Sarepta stock jumps as FDA may lift ELEVIDYS pause after safety review
Investing 11:38 Sarepta Therapeutics stock price target raised to $5 from $0 at H.C. Wainwright
Benzinga 09:41 Sarepta Therapeutics Surges Over 40% In Tuesday Pre-Market: What's Going On? - Arrowhead Pharma (NASDAQ:ARWR), Sarepta Therapeutics (NASDAQ:SRPT)
Investing 08:54 Bernstein initiates Sarepta Therapeutics stock with Market Perform rating
Investing 08:08 Sarepta Therapeutics stock rating upgraded by JPMorgan on FDA decision
Benzinga 12:48 FDA Probes Death Of 8-Year-Old Who Received Sarepta's Elevidys - Sarepta Therapeutics (NASDAQ:SRPT)
Investing 11:55 H.C. Wainwright reiterates Sell rating on Sarepta Therapeutics stock with $0 target
Investing 07:38 Barclays downgrades Sarepta stock to Underweight on Elevidys concerns
Benzinga 15:09 Sarepta Gets Thumbs Down From Regulators Regarding Gene Therapy - Sarepta Therapeutics (NASDAQ:SRPT)
Investor's Business Daily 14:04 Sarepta Therapeutics' Brutal Week Continues With Bad News Out Of Europe
Investing 18:01 Eli Lilly, GE Vernova Surge Among Wednesday’s Market Cap Stock Movers
Benzinga 15:00 GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Arrowhead Pharma (NASDAQ:ARWR), Abivax (NASDAQ:ABVX)
Seeking Alpha 17:30 How Negative Developments At Sarepta Impact Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Investor's Business Daily 12:58 Sarepta Makes A 'Painful' Decision. Will It Help Rebuild Investors' Confidence?
Benzinga 12:56 Sarepta Pauses Elevidys Shipments Amid FDA Safety Review - Sarepta Therapeutics (NASDAQ:SRPT)
Investing 18:01 Google, Linde lead market cap stock movers on Monday
Investing 18:01 Netflix, Abbott Labs Lead Friday’s Market Cap Stock Movers
Zacks 14:58 SRPT Stock Soars on Unveiling New Restructuring Plan, Pipeline Pivots
Investing 15:17 CRISPR Therapeutics stock maintains outperform rating at William Blair
Investing 11:44 Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran
Investing 21:20 Factbox-Fat, not muscle: Drugmakers in race for next weight-loss breakthrough
Reuters 14:41 Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Investing 19:07 Arrowhead Pharmaceuticals at Goldman Sachs Conference: Strategic Launch Plans
Investing 15:31 Arrowhead at Jefferies Conference: Strategic Pipeline Insights

Tagesspanne

15.51 16.54

Jahresspanne

9.57 28.72

Vorheriger Schlusskurs: 15.92
Eröffnung: 16.26

Bid: 15.70
Ask: 16.00

Tief: 15.51
Hoch: 16.54

Volumen: 3.667 K

Tagesänderung: -3.44%
Monatsänderung: 0.26%

6-Monatsänderung: -18.06%
Jahresänderung: -44.82%

30 Juli, Mittwoch